// App-Quantinova.ai

380 : Changes in Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Ixekizumab in a Real-World US Cohort

Researchers

Presenter

  • William Tillett

Principal Investigators

  • Julie Birt

  • Cristi Cavanaugh

  • Yoojin Jung

  • Aisha Vadhariya

  • Sarah Ross

  • Jessica Paulus

  • Aubrey Sprabery

  • Ennio Lubrano

Medical Centers

  • 15. Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute ’Vincenzo Tiberio’, University of Molise, Campobasso, Italy

  • Eli Lilly and Company, Indianapolis, IN

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

Locations

  • United Kingdom

  • United States

  • Italy

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • N/A

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved